Header Logo

Connection

THOMAS A ALOIA to Colorectal Neoplasms

Back to Details
This is a "connection" page, showing publications THOMAS A ALOIA has written about Colorectal Neoplasms.
THOMAS A ALOIA
Connection Strength
4.817
Colorectal Neoplasms
  1. Enhanced recovery in liver surgery. J Surg Oncol. 2019 Apr; 119(5):660-666.
    View in: PubMed
    Score: 0.229
  2. Fancier and More Expensive Doesn't Mean Better: An Argument for CT Staging of Patients with Colorectal Liver Metastases. Ann Surg Oncol. 2017 12; 24(Suppl 3):603-604.
    View in: PubMed
    Score: 0.209
  3. Inflammation and pro-resolution inflammation after hepatobiliary surgery. World J Surg Oncol. 2017 Aug 10; 15(1):152.
    View in: PubMed
    Score: 0.206
  4. Hammer versus Swiss Army knife: Developing a strategy for the management of bilobar colorectal liver metastases. Surgery. 2017 07; 162(1):12-17.
    View in: PubMed
    Score: 0.198
  5. RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases. J Gastrointest Surg. 2017 01; 21(1):68-77.
    View in: PubMed
    Score: 0.190
  6. Insights into ALPPS. Eur J Surg Oncol. 2015 May; 41(5):610-1.
    View in: PubMed
    Score: 0.173
  7. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol. 2014 Aug; 110(2):107-14.
    View in: PubMed
    Score: 0.165
  8. Colorectal liver metastases. J Gastrointest Surg. 2013 Jan; 17(1):195-201; quiz p.201-2.
    View in: PubMed
    Score: 0.147
  9. Management of colorectal liver metastases: past, present, and future. Updates Surg. 2011 Mar; 63(1):1-3.
    View in: PubMed
    Score: 0.132
  10. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol. 2009 Mar 10; 27(8):1343-5; author reply 1345.
    View in: PubMed
    Score: 0.115
  11. A decision analysis model predicts the optimal treatment pathway for patients with colorectal cancer and resectable synchronous liver metastases. Clin Colorectal Cancer. 2008 May; 7(3):197-201.
    View in: PubMed
    Score: 0.108
  12. Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol. 2007 Oct 10; 25(29):4593-602.
    View in: PubMed
    Score: 0.104
  13. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol. 2006 Nov 01; 24(31):4983-90.
    View in: PubMed
    Score: 0.098
  14. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg. 2006 May; 141(5):460-6; discussion 466-7.
    View in: PubMed
    Score: 0.094
  15. Survival by Number and Sites of Resections of Recurrence after First Curative Resection of Colorectal Liver Metastases. J Gastrointest Surg. 2022 12; 26(12):2503-2511.
    View in: PubMed
    Score: 0.073
  16. Improved Survival over Time After Resection of Colorectal Liver Metastases and Clinical Impact of Multigene Alteration Testing in Patients with Metastatic Colorectal Cancer. J Gastrointest Surg. 2022 03; 26(3):583-593.
    View in: PubMed
    Score: 0.068
  17. Preliminary Analysis of Liquid Biopsy after Hepatectomy for Colorectal Liver Metastases. J Am Coll Surg. 2021 07; 233(1):82-89.e1.
    View in: PubMed
    Score: 0.066
  18. Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis. Ann Surg Oncol. 2021 Mar; 28(3):1457-1465.
    View in: PubMed
    Score: 0.065
  19. RAS/TP53 Co-mutation is Associated With Worse Survival After Concurrent Resection of Colorectal Liver Metastases and Extrahepatic Disease. Ann Surg. 2022 08 01; 276(2):357-362.
    View in: PubMed
    Score: 0.065
  20. APC and PIK3CA Mutational Cooperativity Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colorectal Liver Metastases. Ann Surg. 2020 12; 272(6):1080-1085.
    View in: PubMed
    Score: 0.065
  21. Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases. J Gastrointest Surg. 2021 01; 25(1):186-194.
    View in: PubMed
    Score: 0.065
  22. A New Surveillance Algorithm After Resection of Colorectal Liver Metastases Based on Changes in Recurrence Risk and RAS Mutation Status. J Natl Compr Canc Netw. 2020 11; 18(11):1500-1508.
    View in: PubMed
    Score: 0.064
  23. Choices of Therapeutic Strategies for Colorectal Liver Metastases Among Expert Liver Surgeons: A Throw of the Dice? Ann Surg. 2020 11; 272(5):715-722.
    View in: PubMed
    Score: 0.064
  24. Anatomic Resection Is Not Required for Colorectal Liver Metastases with RAS Mutation. J Gastrointest Surg. 2020 05; 24(5):1033-1039.
    View in: PubMed
    Score: 0.062
  25. Comment on Letter to the Editor Regarding "ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: When Innovation is Not Enough". Ann Surg. 2019 08; 270(2):e35-e36.
    View in: PubMed
    Score: 0.059
  26. Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases. Clin Cancer Res. 2019 10 01; 25(19):5843-5851.
    View in: PubMed
    Score: 0.059
  27. Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation. J Am Coll Surg. 2019 09; 229(3):286-294.e1.
    View in: PubMed
    Score: 0.058
  28. Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases. Ann Surg. 2019 05; 269(5):917-923.
    View in: PubMed
    Score: 0.058
  29. RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases. Ann Surg. 2019 01; 269(1):120-126.
    View in: PubMed
    Score: 0.057
  30. Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2019 Jan; 26(1):275-281.
    View in: PubMed
    Score: 0.056
  31. Loss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases. Surgery. 2019 02; 165(2):329-336.
    View in: PubMed
    Score: 0.055
  32. Surgical Resection for Recurrence After Two-Stage Hepatectomy for Colorectal Liver Metastases Is Feasible, Is Safe, and Improves Survival. J Gastrointest Surg. 2019 01; 23(1):84-92.
    View in: PubMed
    Score: 0.055
  33. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases. Eur J Surg Oncol. 2018 05; 44(5):684-692.
    View in: PubMed
    Score: 0.054
  34. Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases. Ann Surg. 2018 03; 267(3):514-520.
    View in: PubMed
    Score: 0.053
  35. Two-Stage Hepatectomy vs One-Stage Major Hepatectomy with Contralateral Resection or Ablation for Advanced Bilobar Colorectal Liver Metastases. J Am Coll Surg. 2018 05; 226(5):825-834.
    View in: PubMed
    Score: 0.053
  36. Impact of Prior Hepatectomy History on Local Tumor Progression after Percutaneous Ablation of Colorectal Liver Metastases. J Vasc Interv Radiol. 2018 03; 29(3):395-403.e1.
    View in: PubMed
    Score: 0.053
  37. Comprehensive Complication Index Predicts Cancer-specific Survival After Resection of Colorectal Metastases Independent of RAS Mutational Status. Ann Surg. 2017 12; 266(6):1045-1054.
    View in: PubMed
    Score: 0.053
  38. Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis. Eur J Surg Oncol. 2018 01; 44(1):122-129.
    View in: PubMed
    Score: 0.052
  39. Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter? Ann Surg Oncol. 2018 Jan; 25(1):179-187.
    View in: PubMed
    Score: 0.052
  40. Remnant Liver Ischemia as a Prognostic Factor for Cancer-Specific Survival After Resection of Colorectal Liver Metastases. JAMA Surg. 2017 Oct 18; 152(10):e172986.
    View in: PubMed
    Score: 0.052
  41. Operative and short-term oncologic outcomes of laparoscopic versus open liver resection for colorectal liver metastases located in the posterosuperior liver: a propensity score matching analysis. Surg Endosc. 2018 04; 32(4):1776-1786.
    View in: PubMed
    Score: 0.052
  42. ERAS-Anticipated outcomes and realistic goals. J Surg Oncol. 2017 Oct; 116(5):570-577.
    View in: PubMed
    Score: 0.052
  43. Hepatic atrophy following preoperative chemotherapy predicts hepatic insufficiency after resection of colorectal liver metastases. J Hepatol. 2017 07; 67(1):56-64.
    View in: PubMed
    Score: 0.050
  44. Total Transthoracic Approach Facilitates Laparoscopic Hepatic Resection in Patients with Significant Prior Abdominal Surgery. Ann Surg Oncol. 2017 May; 24(5):1376-1377.
    View in: PubMed
    Score: 0.049
  45. Is hepatectomy justified for patients with RAS mutant colorectal liver metastases? An analysis of 524 patients undergoing curative liver resection. Surgery. 2017 02; 161(2):332-340.
    View in: PubMed
    Score: 0.048
  46. RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2016 08; 23(8):2635-43.
    View in: PubMed
    Score: 0.047
  47. Eradication of Missing Liver Metastases After Fiducial Placement. J Gastrointest Surg. 2016 06; 20(6):1173-8.
    View in: PubMed
    Score: 0.046
  48. Predictors of Safety and Efficacy of 2-Stage Hepatectomy for Bilateral Colorectal Liver Metastases. J Am Coll Surg. 2016 07; 223(1):99-108.
    View in: PubMed
    Score: 0.046
  49. Positive Impact of Epidural Analgesia on Oncologic Outcomes in Patients Undergoing Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2016 Mar; 23(3):1003-11.
    View in: PubMed
    Score: 0.045
  50. Is complete liver resection without resection of synchronous lung metastases justified? Ann Surg Oncol. 2015 May; 22(5):1585-92.
    View in: PubMed
    Score: 0.042
  51. RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastases. Ann Surg Oncol. 2015 Mar; 22(3):834-842.
    View in: PubMed
    Score: 0.042
  52. Efficacy and safety of portal vein embolization for two-stage hepatectomy in patients with colorectal liver metastasis. J Vasc Interv Radiol. 2014 Apr; 25(4):608-17.
    View in: PubMed
    Score: 0.040
  53. Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients. J Gastrointest Surg. 2014 Jan; 18(1):45-51.
    View in: PubMed
    Score: 0.039
  54. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Ann Surg. 2013 Oct; 258(4):619-26; discussion 626-7.
    View in: PubMed
    Score: 0.039
  55. Intrabiliary growth of colorectal liver metastasis: spectrum of imaging findings and implications for surgical management. AJR Am J Roentgenol. 2013 Oct; 201(4):W582-9.
    View in: PubMed
    Score: 0.039
  56. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg. 2013 Jun; 257(6):1079-88.
    View in: PubMed
    Score: 0.038
  57. AHPBA/SSO/SSAT sponsored consensus conference on the multidisciplinary treatment of colorectal cancer metastases. HPB (Oxford). 2013 Feb; 15(2):89-90.
    View in: PubMed
    Score: 0.038
  58. Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford). 2013 Feb; 15(2):91-103.
    View in: PubMed
    Score: 0.038
  59. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol. 2012 Dec 20; 30(36):4566-72.
    View in: PubMed
    Score: 0.037
  60. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases. Ann Surg. 2012 Oct; 256(4):642-50.
    View in: PubMed
    Score: 0.037
  61. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis. Ann Surg Oncol. 2013 Feb; 20(2):482-90.
    View in: PubMed
    Score: 0.037
  62. Optimizing clinical and economic outcomes of surgical therapy for patients with colorectal cancer and synchronous liver metastases. J Am Coll Surg. 2012 Aug; 215(2):262-70.
    View in: PubMed
    Score: 0.036
  63. Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. HPB (Oxford). 2011 Nov; 13(11):774-82.
    View in: PubMed
    Score: 0.034
  64. Chemotherapy-associated hepatotoxicity: how concerned should we be? Expert Rev Anticancer Ther. 2010 Apr; 10(4):521-7.
    View in: PubMed
    Score: 0.031
  65. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol. 2008 Aug 01; 26(22):3672-80.
    View in: PubMed
    Score: 0.028
  66. Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol. 2008 Apr 01; 26(10):1635-41.
    View in: PubMed
    Score: 0.027
  67. Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases. Surg Oncol Clin N Am. 2007 Jul; 16(3):525-36, viii.
    View in: PubMed
    Score: 0.026
  68. Parenchymal-sparing Hepatectomy in Colorectal Liver Metastasis Improves Salvageability and Survival. Ann Surg. 2016 Jan; 263(1):146-52.
    View in: PubMed
    Score: 0.012
  69. Simultaneous lung resection via a transdiaphragmatic approach in patients undergoing liver resection for synchronous liver and lung metastases. Surgery. 2014 Nov; 156(5):1197-203.
    View in: PubMed
    Score: 0.010
  70. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg. 2013 Feb; 216(2):201-9.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.